Bristol-Myers Misses Estimates as Cancer, Virus Drug Sales Slow
Bristol-Myers Squibb Co. reported fourth-quarter profit that fell short of analysts' estimates as sales slowed for its virology drugs and cancer treatment Yervoy.
from Biotech News
Bristol-Myers Squibb Co. reported fourth-quarter profit that fell short of analysts' estimates as sales slowed for its virology drugs and cancer treatment Yervoy.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments